Continuous Glucose Monitoring (CGM) After Kidney Transplantation

Recruiting now

Conditions studied: Hyperglycaemia, Kidney Transplantation

In brief

This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glucose between these three groups. CGMs are applied to participants within 72 hours after kidney transplantation, with a total of 54 participants divided equally across the three groups (18 in each). Secondary objectives include assessing additional glucose profile indices, adherence to relevant guidelines, changes in HbA1c, the impact of immunosuppression and steroid dosage, and beta cell function.

Key facts

Study ID

NCT06675903

Run by

Bo Feldt-Rasmussen

People needed

54

Starts

2024-11-12

Expected to finish

2026-01-01

Last updated by the study team

2024-11-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent obtained before CGM application
• Male or female; age: ≥18 years
• Kidney transplantation

You may not qualify if…

• Unable to cooperate to CGM the first ten days after surgery
• Allergic to plasters in CGM units
• Combined kidney and liver or pancreatic transplantation
• Graft loss/rejection within first 48 hours after transplantation

Where it is running

• Rigshospitalet — Copenhagen, DK, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.